Cimzia 2X200 MG/ML syringe kits
Ended Awarded Last action
- Contract number
- SPE2DR26FM8Z0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,463
Award facts
- Contract value 100% obligated
- $10,462.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,462.64 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 6, 2026, for the supply of CIMZIA 2X200 mg/ml syringe kits, with an ultimate completion date of January 7, 2026. This firm fixed-price contract, which was not set aside for small business or other designated categories, represents a direct purchase order executed under the company's existing indefinite delivery contract with DLA Troop Support Medical. The contractor is headquartered in Conshohocken, Pennsylvania, which also serves as the place of performance for this order. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (formerly AmerisourceBergen), a major pharmaceutical distributor supplying critical medical commodities to federal healthcare systems.
This delivery order falls under Cencora, Inc.'s substantial $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical through December 2026, which serves as the primary vehicle for delivering pharmaceuticals and medical supplies to support military healthcare programs globally. CIMZIA (certolizumab pegol) is a prescription biologic medication used to treat autoimmune inflammatory conditions, and this order reflects the routine pharmaceutical replenishment requirements of the Defense Health Agency and other federal medical institutions. The rapid completion timeline—with award and fulfillment occurring on consecutive days—demonstrates the operational efficiency of the indefinite delivery contract framework in responding to time-sensitive medical supply needs within the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FM8Z0?
SPE2DR26FM8Z0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FM8Z0 worth?
The government has obligated $10,463 on SPE2DR26FM8Z0.
Is contract SPE2DR26FM8Z0 an order under another contract?
Yes. SPE2DR26FM8Z0 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM8Z0 competed?
The extent of competition for SPE2DR26FM8Z0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award